Literature DB >> 29952099

AHNS Series: Do you know your guidelines? Principles for treatment of cancer of the paranasal sinuses: A review of the National Comprehensive Cancer Network guidelines.

J Kenneth Byrd1, Jon Mallen-St Clair2, Ivan El-Sayed3.   

Abstract

This article is a continuation of the "Do You Know Your Guidelines" series. This was launched as an initiative of the American Head and Neck Society to increase the awareness of current best practices pertaining to head and neck cancer. The National Comprehensive Cancer Network (NCCN) guidelines for managing cancer of the paranasal sinuses are reviewed in a systematic fashion. These guidelines outline the workup, treatment, and surveillance of patients with cancer of the maxillary and ethmoid sinuses.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  National Comprehensive Cancer Network (NCCN); cancer; ethmoid sinus; maxillary sinus; paranasal sinus

Mesh:

Year:  2018        PMID: 29952099     DOI: 10.1002/hed.25143

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Epigenetic regulation of p62/SQSTM1 overcomes the radioresistance of head and neck cancer cells via autophagy-dependent senescence induction.

Authors:  Myungjin Lee; Hae Yun Nam; Hee-Bum Kang; Won Hyeok Lee; Geun-Hee Lee; Gi-Jun Sung; Myung Woul Han; Kyung-Ja Cho; Eun-Ju Chang; Kyung-Chul Choi; Seong Who Kim; Sang Yoon Kim
Journal:  Cell Death Dis       Date:  2021-03-05       Impact factor: 8.469

2.  A Competing Risk Nomogram for Predicting Cancer-Specific Death of Patients With Maxillary Sinus Carcinoma.

Authors:  Mingbin Hu; Xiancai Li; Weiguo Gu; Jinhong Mei; Dewu Liu; Shaoqing Chen
Journal:  Front Oncol       Date:  2021-08-24       Impact factor: 6.244

3.  Actinidia chinensis Planch Root extract suppresses the growth and metastasis of hypopharyngeal carcinoma by inhibiting E2F Transcription Factor 1-mediated MNX1 antisense RNA 1.

Authors:  Yi Zheng; Lizhong Su; Jun Tan; Feilin Dong
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

4.  Retrospective analysis of 98 cases of maxillary sinus squamous cell carcinoma and therapeutic exploration.

Authors:  Yu Wang; Rong Yang; Minghui Zhao; Wenyu Guo; Lun Zhang; Wenchao Zhang; Xudong Wang
Journal:  World J Surg Oncol       Date:  2020-05-06       Impact factor: 2.754

5.  Real-World Outcomes and Prognostic Factors in Patients Receiving Nivolumab Therapy for Recurrent or Metastatic Head and Neck Carcinoma.

Authors:  Ryusuke Hori; Shogo Shinohara; Tsuyoshi Kojima; Hiroki Kagoshima; Morimasa Kitamura; Ichiro Tateya; Hisanobu Tamaki; Yohei Kumabe; Ryo Asato; Hiroyuki Harada; Yoshiharu Kitani; Takashi Tsujimura; Keigo Honda; Kazuyuki Ichimaru; Koichi Omori
Journal:  Cancers (Basel)       Date:  2019-09-06       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.